Trials / Completed
CompletedNCT00772564
The Use of Statins for Myocardial Death Prevention
The Use of Statins for Myocardial Death Prevention: From Cell to Bedside
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Rambam Health Care Campus · Academic / Other
- Sex
- All
- Age
- 30 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The administration of high dose HMG-CoA reductase inhibitors (Statins) to patients with acute ST-elevation MI (hypoxia/ischemia) who are treated with primary PCI (reoxygenation/ reperfusion) will protect their cardiomyocytes from death and thus preserve LV ejection fraction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | Oral Atorvastatin |
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2010-06-01
- Completion
- 2010-08-01
- First posted
- 2008-10-15
- Last updated
- 2012-05-28
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00772564. Inclusion in this directory is not an endorsement.